Aug 23, 2024 / 08:00AM GMT
Erik Manting - Mendus AB(publ)-Chief Executive Officer
Good morning, everyone. Thanks to Mendus Q2 2024 for business update. My name is Erik Manting, CEO of Mendus. And today I'm joined by our Chief Medical Officer, Jeroen Rovers; and CFO, Lotta Ferm.
As a summary of the second quarter of 2024, we raised roughly SEK69 million in April through the exercise of warrants that were associated with the financing that we carried out in 2023, sorry, with participation of all major shareholders Management (inaudible) Board members. We're are very happy with our current shareholder bases and also with the fact that they all contribute to this part of the financing.
We also had some Board changes and importantly, a new Chairman of the Board in (inaudible) on the very happy (inaudible) to step up to this role. He is someone with a very broad experience, both in Europe and the US and has been on both sides in the pharmaceutical industry and the biotech industry and brings a lot of also business development expertise.
So we're happy with China's new Chairman
Q2 2024 Mendus AB (publ) Earnings Call Transcript
Aug 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers